课题基金 / 基金详情

FASEB's The Reversible Protein Acetylation in Health and Disease Conference

FASEB's The Reversible Protein Acetylation in Health and Disease Conference
FASEB 健康与疾病中的可逆蛋白质乙酰化会议
批准号:
10230422
负责人:
Jessica K Tyler
金额:
$0.8万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2023-08-31
关键词:
AcetylationAcetyltransferaseAgingAllyAmericanAntineoplastic AgentsArchitectureAreaBasic ScienceBindingBinding ProteinsBiochemistryBiologicalBiologyBromodomainCancer EtiologyCarbonCationsCell Cycle ProgressionCell ProliferationCellsCellular biologyChargeChemicalsChemopreventionClinicalClinical ResearchCollaborationsCommunitiesCountryDNA RepairDNA biosynthesisDeacetylaseDevelopmentDietary InterventionDiseaseDockingDrug TargetingEatingEnzyme InteractionEnzymesEtiologyEuropeanFDA approvedFacultyFemaleFertilizationFosteringGene ExpressionGeneticGenetic TranscriptionGenomeGenome StabilityGermanyGoalsGrowthGrowth and Development functionHealthHistone DeacetylaseHistone Deacetylase InhibitorHomeostasisHumanImmune responseIndustrializationIndustryInternationalInvestigationItalyKnowledgeLinkLondonLongevityLysineMalignant NeoplasmsMedicalMentorsMetabolic DiseasesMetabolismMethylationMitochondriaModificationMolecularMolecular BiologyMolecular Mechanisms of ActionMontanaN-terminalNew AgentsNuclearOralParticipantPathway interactionsPatientsPatternPharmacologyPhosphorylationPlayPortugalPost-Translational Protein ProcessingPremature aging syndromePrizeProcessProtein AcetylationProtein SecretionProteinsPublic HealthPuerto RicoReaderRegulationReportingResearchResearch PersonnelResortRoleScientistSideSignal TransductionSirtuinsSiteStructureSumoylation PathwaySurfaceTalentsTechnologyTestingTherapeuticTherapeutic InterventionTherapeutic UsesTimeTrainingTumor Suppressor GenesUnderrepresented Minorityage relatedbasecancer cellcancer therapycareercareer developmentdrug discoveryepigenetic regulationepigenetic silencingepigenomegraduate studenthistone acetyltransferasehuman diseaseimprovedinhibitor/antagonistinnovationinsightinterestmeetingsnovel therapeutic interventionnovel therapeuticsoverexpressionpalmitoylationposterspreventprotein functionresponsestem cell functionstem cellssuccesssummer researchsymposiumtherapeutic target

项目摘要

项目成果

Jessica K Tyler的其他基金

相似基金

相关文献

中文摘要
翻译
摘要
英文摘要
Abstract Over the past few years, the “epigenetic” regulation of the genome has become increasingly important to understanding both the etiology and fundamental mechanisms of aging and age-related diseases. Key to epigenetic regulation are two classes of lysine-modifying enzymes, the histone deacetylases (sirtuins and HDACs) and the histone acetyltransferases (HATs), also known as erasers and writers, respectively. Acetyl- lysine neutralizes the cationic charge relative to the naked Lys sidechain and also creates an attractive surface for binding to proteins containing bromodomains, also known as reader proteins. These acetyl-Lys writers, erasers, and readers are critical for maintaining normal expression patterns, cell cycle progression, DNA repair, stem cells, mitochondria, cell fate, and differentiation. Alterations in the functions of these acetyl-Lys related proteins have been linked to epigenetic silencing of gene expression including tumor suppressor genes, leading to cancer cell proliferation. Moreover, changes in acetyl-Lys pathways are believed to contribute to a variety of other diseases and aging mechanisms. Several broad spectrum HDAC inhibitors have been approved by FDA to treat various cancers. Their precise molecular mechanisms in controlling cancer and influencing other biomedical processes remain elusive. Targeting HATs and HDACs for therapeutic purposes has been an area of great interest and success, and exciting new progress has also been made in recent years in targeting interactions between readers and acetylated lysines in cancer and other diseases. As the only conference dedicated to protein acetylation, this biannual meeting plays an essential role in bringing together more than 40 world leaders and ~120 participants. A primary objective is to transfer knowledge and foster collaboration between basic academic researchers, clinical scientists, and industrial researchers to understand how lysine acetylation controls human health and how to prevent and treat a diverse set of cancers and age-related diseases. A second objective is to foster the development and interests of younger investigators to help support their career development. The participants stay and eat at the meeting venue so they have ample time to for informal brainstorming and networking. There are 16 planned talks from junior scientists selected from the submitted abstracts and poster prize winners, which is important for their career development. We will also have a panel discussion on professional development and career options, aimed to provide further support for the young investigators. Moreover, there will be a diversity networking session, and multiple meet the speaker sessions that will be highlighted at the meeting. This meeting is particularly timely because of a linkage of acetylation, metabolism, and cancer. Furthermore, exciting new fundamental discoveries are continuing to be reported, such as the discovery of new lysine post-translational modifications (e.g. 3-hydroxybutyryl lysine and palmitoyl lysine) that can be removed by sirtuins or HDACs, and the discovery that these modifications can regulate transcription, cell signaling, and protein secretion. Therefore, support is requested for the 8th biannual FASEB conference on reversible protein acetylation in health and disease to be held in Dorado, Puerto Rico on August 9-14, 2021.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovering how autophagy is sufficient to extend yeast replicative lifespan
2nd Biennial ASBMB - BSC Symposium on the Interplay between Epigenetic Regulation and Genome Integrity
Novel pathways that regulate DNA double-strand break repair events in mammalian cells
Novel pathways that regulate DNA double-strand break repair events in mammalian cells
海外基金